September 2026 Options Now Available For Medtronic (MDT)

Stock Options Channel highlights potential options strategies for Medtronic PLC (MDT), focusing on a $77.50 put contract and an $82.50 call contract. Selling the $77.50 put offers a potential 6.45% return if it expires worthless, with a 62% probability of that outcome. Conversely, a covered call strategy using the $82.50 call could yield a 10.47% return if the stock is called away, but carries a 46% chance of expiring worthless, providing a 7.55% yield boost; implied volatilities for the put and call options are 25% and 24%, respectively, compared to the stock's trailing twelve-month volatility of 22%.

Analysis

Medtronic PLC (MDT) presents option-based strategies for potential income generation or stock acquisition at a discount. Selling the $77.50 strike put contract, currently bid at $5.00, offers an investor a potential entry point at an effective cost basis of $72.50 per share, a discount to the current $80.16 price. This out-of-the-money put has a 62% statistical probability of expiring worthless, which would result in a 6.45% return on cash commitment (4.88% annualized YieldBoost). Alternatively, for existing MDT shareholders, selling the $82.50 strike call contract, bid at $6.05, as a covered call could generate a 10.47% total return (excluding dividends) if shares are called away at the September 2026 expiration. There is a 46% chance this call expires worthless, providing a 7.55% premium (5.70% annualized YieldBoost) while retaining the shares, though this strategy caps upside potential if MDT's stock price significantly appreciates. The implied volatility for the put is 25% and for the call is 24%, both slightly above MDT's trailing twelve-month actual volatility of 22%, suggesting option premiums may be modestly elevated.

Key Decisions for Investors

• Investors bullish on Medtronic PLC and willing to acquire shares at a lower price could consider selling the $77.50 puts to either purchase MDT at an effective cost of $72.50 or earn a 6.45% premium if the option expires worthless.
• Current Medtronic shareholders seeking to generate income could evaluate writing $82.50 covered calls, potentially earning a 7.55% YieldBoost if the option expires worthless or achieving a 10.47% total return if called away by September 2026, while understanding this limits further upside.
• Given that implied volatilities of 24-25% exceed the stock's 22% historical volatility, option selling strategies might be relatively more attractive than buying options on MDT at current levels, though fundamental analysis of the company remains crucial.